UBS initiates Vikram Solar stock with Neutral rating, cites capex risks

UBS initiated coverage on Vikram Solar (VIKRAMSO:IN) with a Neutral rating and a price target of INR355.00, citing a balanced risk-reward profile. The investment bank noted the solar module manufacturer's ambitious expansion plans to significantly increase module and cell manufacturing capacity, driven by strong demand in the Indian market. However, UBS highlighted potential challenges with cell ramp-up timelines and future capital expenditure for upstream integration, though it believes the current valuation, reflecting a 30% discount to peers, adequately accounts for these risks.

Analysis

UBS has initiated coverage on Vikram Solar (VIKRAMSO:IN) with a Neutral rating and a price target of INR355.00, signaling a balanced risk-reward profile. The initiation is contextualized by strong domestic demand for solar components in the Indian market, which supports Vikram Solar's ambitious strategy to expand its module capacity from 4.5GW to 17.5GW by FY27 and establish 12GW of cell manufacturing capacity by FY28. However, UBS tempers this growth outlook by highlighting significant execution risks, noting that the cell manufacturing ramp-up could be slower than projected, a common challenge across the industry. Furthermore, the analysis points to a potential long-term strategic risk post-FY28, where value in the solar supply chain may migrate upstream to wafers and ingots, necessitating further capital expenditure for Vikram Solar to remain competitive. UBS concludes that the company's current valuation, which reflects an approximate 30% discount to its peers, adequately incorporates these challenges related to operational timelines and future capital requirements.

Key Decisions for Investors

• Given the Neutral rating, investors should consider the current 30% valuation discount to peers as fair compensation for the noted execution risks in cell manufacturing and future capital expenditure needs.
• Monitor the company's progress on its capacity expansion targets, as any significant delays in the cell manufacturing ramp-up to 12GW by FY28 could validate UBS's cautious outlook and justify the valuation discount.
• Long-term investors should track developments in the Indian solar supply chain, particularly any shift towards domestic wafer and ingot production, which would be a critical indicator of future capital requirements for Vikram Solar.